Osaic Holdings
AVIR icon

Osaic Holdings’s Atea Pharmaceuticals AVIR Stock Holding History

Osaic Holdings’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.77K Buy
1,026
+1
+0.1% +$5 ﹤0.01% 6958
2026
Q1 		$5.51K Sell
1,025
-300
-23% -$1.38K ﹤0.01% 6636
2025
Q4 		$4.73K Hold
1,325
– – ﹤0.01% 6736
2025
Q3 		$3.87K Sell
1,325
-5
-0.4% -$17 ﹤0.01% 6888
2025
Q2 		$4.79K Sell
1,330
-45
-3% -$134 ﹤0.01% 6563
2025
Q1 		$4.11K Sell
1,375
-2,925
-68% -$9.13K ﹤0.01% 6274
2024
Q4 		$14.4K Sell
4,300
-533
-11% -$1.77K ﹤0.01% 5559
2024
Q3 		$16.2K Buy
4,833
+1,033
+27% +$3.75K ﹤0.01% 5503
2024
Q2 		$12.6K Sell
3,800
-3,526
-48% -$13.1K ﹤0.01% 5641
2024
Q1 		$29.6K Hold
7,326
– – ﹤0.01% 5107
2023
Q4 		$22.3K Sell
7,326
-1,825
-20% -$5.53K ﹤0.01% 5440
2023
Q3 		$27.5K Buy
9,151
+1,997
+28% +$6.79K ﹤0.01% 5379
2023
Q2 		$26.8K Buy
7,154
+3,453
+93% +$12.9K ﹤0.01% 5375
2023
Q1 		$12.4K Sell
3,701
-70
-2% -$284 ﹤0.01% 5849
2022
Q4 		$19K Sell
3,771
-421
-10% -$2.13K ﹤0.01% 5596
2022
Q3 		$24K Hold
4,192
– – ﹤0.01% 5430
2022
Q2 		$29K Buy
4,192
+122
+3% +$833 ﹤0.01% 5352
2022
Q1 		$28K Buy
4,070
+1,794
+79% +$12.2K ﹤0.01% 5464
2021
Q4 		$20K Buy
2,276
+1,950
+598% +$30.4K ﹤0.01% 5780
2021
Q3 		$11K Buy
326
+150
+85% +$4.16K ﹤0.01% 6130
2021
Q2 		$4K Buy
+176
New +$5.29K ﹤0.01% 6456

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Osaic Holdings's AVIR Position: Q2 2026 in Review

Osaic Holdings increased its Atea Pharmaceuticals (AVIR) stake by 0.1% in Q2 2026, buying an estimated $5 and bringing the position to 1,026 shares worth $4.77K. The position accounts for ﹤0.01% of the portfolio, ranked #6958.

Osaic Holdings first reported a position in AVIR in Q2 2021 and has held it in 21 quarters since. The position peaked at $29.6K in Q1 2024. 124 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • Osaic Holdings held 1,026 shares of Atea Pharmaceuticals worth $4.77K as of Q2 2026.
  • Osaic Holdings bought 1 Atea Pharmaceuticals share in Q2 2026, an estimated $5.
  • Atea Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6958 holding.
  • Osaic Holdings first reported a position in Atea Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • Osaic Holdings's Atea Pharmaceuticals position peaked at $29.6K in Q1 2024.
  • 124 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.